publication venue for Escitalopram: an open-label study of bereavement-related depression and grief.. 113:142-149. 2009 Going up in smoke: tobacco smoking is associated with worse treatment outcomes in mania.. 110:126-134. 2008 Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study.. 106:63-72. 2008 Suicidal events and accidents in 216 first-episode bipolar I disorder patients: predictive factors.. 106:179-184. 2008 The empirical redefinition of the psychometric criteria for remission in bipolar disorder.. 106:153-158. 2008 Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.. 105:101-108. 2008 Effect of comorbid anxiety on treatment response in bipolar depression.. 104:137-146. 2007 Depression and suicidality in HIV/AIDS in China.. 94:269-275. 2006 Clinical relevance of depressive symptom improvement in bipolar I depressed patients.. 92:261-266. 2006 Psychopathology of panic attacks in panic disorder.. 92:55-62. 2006 Treatment of bereavement-related depression and traumatic grief.. 92:117-124. 2006 Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data.. 89:69-77. 2005 Quality of life assessment in patients with bipolar disorder treated with olanzapine added to lithium or valproic acid.. 81:223-229. 2004 Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling.. 73:155-161. 2003 Placebo-controlled trials do not find association of olanzapine with exacerbation of bipolar mania.. 73:147-153. 2003 A general anxiety-prone cognitive style in anxiety disorders.. 70:241-249. 2002 Economic, clinical, and quality-of-life outcomes associated with olanzapine treatment in mania. Results from a randomized controlled trial.. 69:109-118. 2002 Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment.. 68:243-249. 2002 Olanzapine versus haloperidol in schizoaffective disorder, bipolar type.. 67:133-140. 2001 Use of olanzapine in dysphoric mania.. 66:247-253. 2001 A meta-analysis of the use of typical antipsychotic agents in bipolar disorder.. 65:85-93. 2001 The revised Anxious Thoughts and Tendencies (AT&T) scale: a general measure of anxiety-prone cognitive style.. 52:51-58. 1999 Pre- and perinatal complications and risk for bipolar disorder: a retrospective study.. 50:117-124. 1998 Panic disorder and agoraphobia: a sufferer's perspective.. 50:65-74. 1998 Medication side effects in anxious patients: negative placebo responses?. 47:183-190. 1998 Shifts in hospital diagnostic frequencies: bipolar disorder subtypes, 1981-1993.. 43:79-84. 1997 Personality dimensions in panic disorder and generalized anxiety disorder.. 37:75-79. 1996 International study of expert judgement on therapeutic use of benzodiazepines and other psychotherapeutic medications: II. Pharmacotherapy of anxiety disorders.. 35:153-162. 1995 Comparison of primary and secondary panic disorder: a preliminary report.. 27:81-86. 1993 Panic disorder and hypochondriacal fears and beliefs.. 24:73-85. 1992 Four-year follow-up of twenty-four first-episode manic patients.. 19:79-86. 1990 Response of panic disorder to fixed doses of alprazolam or imipramine.. 17:261-270. 1989 Panic disorder, agoraphobia, and anxiety-relevant cognitive style.. 11:219-225. 1986 Subject-own-control design in evaluating clinical antidepressant effects.. 4:373-381. 1982